Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 15, 2007
Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidismHiroaki Ogata, Fumihiko Koiwa, Kanji Shishido, et al.
Clinical and Experimental Nephrology|February 25, 2024
A survey of environmental sustainability in Japanese dialysis facilitiesKei Nagai, Katherine Barraclough, Nanae Matsuo, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|July 1, 2014
Treatment of hyperphosphatemia with bixalomer in Japanese patients on long-term hemodialysis with gastrointestinal symptomsKae Ito, Akiko Takeshima, Kanji Shishido, et al.
Atherosclerosis|November 29, 2011
Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patientsHirokazu Honda, Masashi Ueda, Shiho Kojima, et al.
Clinical and Experimental Nephrology|October 21, 2011
Number of enlarged parathyroid glands might be a predictor of cinacalcet response in advanced secondary hyperparathyroidismMasahiro Yamamoto, Hiroaki Ogata, Masahide Mizobuchi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 28, 2010
Detection of peripheral artery disease by duplex ultrasonography among hemodialysis patientsHiroaki Ogata, Chiaki Kumata-Maeta, Kanji Shishido, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|October 17, 2018
Truncal Adiposity Influences High-Density Lipoprotein Cholesterol Levels and Cardiovascular Events in Hemodialysis PatientsGo Takahashi, Hirokazu Honda, Keiko Takahashi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 14, 2023
Long-Term Effect of Denosumab on Bone Disease in Patients with CKDKen Iseri, Masahide Mizobuchi, Renaud Winzenrieth, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2009
Assessment of myeloperoxidase and oxidative alpha1-antitrypsin in patients on hemodialysisHirokazu Honda, Masashi Ueda, Shiho Kojima, et al.
Pageof 3